Abstract
In gastrointestinal stromal tumor (GIST ), the most common human sarcoma, tumor-associated macrophages (TAMs) have been found to be abundant and surprisingly M1-like, exhibiting antitumoral activities. However, TAMs switch to M2-like during the course of imatinib therapy, but upon drug resistance TAMs revert to M1-like. Therefore, the oncologic efficacy of TAM depletion may depend on tumor type and treatment status.
Original language | English |
---|---|
Article number | e28463 |
Journal | OncoImmunology |
Volume | 3 |
Issue number | 4 |
DOIs |
|
State | Published - 2014 |
Keywords
- C/EBPβ
- CSF1R
- Gastrointestinal stromal tumor
- Macrophage
- Tumor-associated macrophage
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology